SGX-523
UNII WH8SQN09KJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Sgx-523, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WH8SQN09KJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1022150-57-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WH8SQN09KJ
CAS Registry Number
1022150-57-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SGX-523
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C18H13N7S
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
BCZUAADEACICHN-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
n1cccc2cc(ccc12)Sc3nnc4ccc(nn43)-c5cnn(c5)C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sgx-523. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

QUINOLINE, 6-((6-(1-METHYL-1H-PYRAZOL-4-YL)-1,2,4-TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)THIO)-

Technical Codes

SGX523
SGX-523